Cameron Health Inc. touts positive clinical trial results, published in the New England Journal of Medicine, for its lead-less S-ICD subcutaneous implantable cardiac defibrillator.
Cameron Health Inc. is touting a clinical trial of its subcutaneous implantable cardiac defibrillator, which eliminates the need for threading electrical leads through blood vessels to the heart.
Results from the study of the San Clemente, Calif.-based -based company's S-ICD System were published in the New England Journal of Medicine this week.
Covidien’s 3-year study results showing positive outcomes for its Urgent PC Neuromodulation system in...
NEC Display Solutions wins 510(k) clearance for its 21-inch medical monitor systems.
J&J's former head of global cardiology makes the jump to CEO at Itamar Medical
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with...